Detecting Prostate Cancer

Brock, Marko; Bodman, Christian von; Palisaar, Jüri; Becker, Wolfgang; Martin-Seidel, Philipp; Noldus, Joachim

doi:10.3238/arztebl.2015.0605

Cited by 10 publications

(4 citation statements)

References 37 publications

(30 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…found a clinically significant CDR of 37.5% in men with elevated PSA using 12-core systemic biopsy which is approximate to sensitivity data obtained in similar studies. 23,24…”

Section: Types Of Prostate Biopsymentioning

confidence: 99%

“…6,22 Brock et al found a clinically significant CDR of 37.5% in men with elevated PSA using 12-core systemic biopsy which is approximate to sensitivity data obtained in similar studies. 23,24 Contemporary MRI-guided biopsy strategies preferentially detect clinically important lesions and offer clear benefits over the traditional systematic biopsy. 25 MRI-guided biopsy involves selective sampling of lesions identified as suspicious on mpMRI.…”

Section: Types Of Prostate Biopsymentioning

confidence: 99%

See 1 more Smart Citation

A review of optimal prostate biopsy: indications and techniques

Streicher

Meyerson

Karivedu

et al. 2019

Therapeutic Advances in Urology

View full text Add to dashboard Cite

Prostate biopsy is the gold standard diagnostic technique for the detection of prostate cancer. Patient selection for prostate biopsy is complex and is influenced by emerging use of prebiopsy imaging. The introduction of the magnetic resonance imaging (MRI)–transrectal ultrasound (TRUS) fusion prostate biopsy has clear advantages over the historical standard of care. There are several biopsy techniques currently utilized with unique advantages and disadvantages. We review and summarize the current body of literature pertaining to when and how a prostate biopsy should be performed. We discuss current recommendations regarding patient selection for biopsy and discuss future directions regarding prebiopsy imaging. We offer a description of the MRI–TRUS fusion biopsy technique and a comparison of many of the currently available fusion software platforms. Articles pertaining to the title were obtained via PubMed index search with relevant keywords supplemented with personal collection of related publications. Prostate biopsy should be considered for patients with gross digital rectal exam (DRE) abnormality, patients with a prostate-specific antigen (PSA) greater than 4 ng/ml, and concomitant risk factors for prostate cancer or patients with lesions identified on multiparametric MRI (mpMRI) with Prostate Imaging Reporting and Data System 2 (PI-RADS2) score of 4 or 5. MRI–TRUS fusion biopsy has demonstrated advantages in cancer detection when compared with TRUS-guided biopsy. There are currently several fusion software platforms available with a variety of biopsy approaches. Future efforts should detail the role of prebiopsy imaging as a triage tool for prostate biopsy. Consensus should be sought regarding the preferred modality of fusion biopsy. Additional data describing each fusion software platform would enable a more rigorous comparison of platform sensitivities.

show abstract

“…found a clinically significant CDR of 37.5% in men with elevated PSA using 12-core systemic biopsy which is approximate to sensitivity data obtained in similar studies. 23,24…”

Section: Types Of Prostate Biopsymentioning

confidence: 99%

Section: Types Of Prostate Biopsymentioning

confidence: 99%

A review of optimal prostate biopsy: indications and techniques

Streicher

Meyerson

Karivedu

et al. 2019

Therapeutic Advances in Urology

View full text Add to dashboard Cite

show abstract

“…With the aid of MRI one can not only identify and localize, for example, cysts or calcifications of the male adnexa, but also often differentiate between recent and older bleeding. Moreover, there are clear indications that MRI may be helpful in detecting prostate cancer (31).…”

Section: Imagingmentioning

confidence: 99%

Hematospermia—a Symptom With Many Possible Causes

Mathers¹,

Degener²,

Sperling³

et al. 2017

Deutsches Ärzteblatt International

View full text Add to dashboard Cite

show abstract

“…The actual ability of the transrectal ultrasound to detect prostate cancer itself is limited, with a sensitivity of about 73.6% and a specificity of 61.3%. Thus, the diagnostic accuracy of prostate biopsies varies with the imaging techniques used [8]. The TRUS prostate biopsy, however, has been demonstrated to have a high specificity of 96% but a sensitivity of only 48% [9].…”

Section: Introductionmentioning

confidence: 99%

Current Approach to Complications and Difficulties during Transrectal Ultrasound-Guided Prostate Biopsies

Osama,

Serboiu,

Taciuc

et al. 2024

JCM

View full text Add to dashboard Cite

Prostate cancer is one of the most common male malignancies worldwide. It affects middle-aged men (45–60 years) and is the leading cause of cancer-related mortality in Western countries. The TRUS (trans rectal ultrasound)-guided prostate biopsy has been a standard procedure in prostate cancer detection for more than thirty years, and it is recommended in male patients with an abnormal PSA (prostate-specific antigens) or abnormalities found during digital rectal examinations. During this procedure, urologists might encounter difficulties which may cause subsequent complications. This manuscript aims to present both the complications and the technical difficulties that may occur during TRUS-guided prostate biopsy, along with resolutions and solutions found in the specialized literature. The conclusions of this manuscript will note that the TRUS-guided prostate biopsy remains a solid, cost-efficient, and safe procedure with which to diagnose prostate cancer. The complications are usually self-limiting and do not require additional medical assistance. The difficulties posed by the procedure can be safely overcome if there are no other available alternatives. Open communication with the patients improves both pre- and post-procedure compliance.

show abstract

Detecting Prostate Cancer

Cited by 10 publications

References 37 publications

A review of optimal prostate biopsy: indications and techniques

A review of optimal prostate biopsy: indications and techniques

Hematospermia—a Symptom With Many Possible Causes

Current Approach to Complications and Difficulties during Transrectal Ultrasound-Guided Prostate Biopsies

Contact Info

Product

Resources

About